HCP Access Only

Survodutide’s Glucagon Gamble

Survodutide pairs GLP-1 with glucagon receptor activity. Could hepatic metabolism and energy expenditure translate into an advantage over GLP-1/GIP therapies?

Log In or Register as a healthcare professional to read the full article.

Cancer

Could GLP-1s Change Your Colorectal Cancer Risk?

Weight-loss drugs are facing a bowel cancer question, but the findings are far from settled. We unpack the GLP-1 research, the distinction between polyps and cancer, and what patients should discuss with their doctor.

Indonesia

The Haze Returns With More Than Just A Cough

As fires burn in Indonesia and Malaysia, Singapore has also recorded unhealthy air. Haze health risks go beyond irritated eyes and coughing. Who needs extra protection, and when should you seek help?

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

Don’t have an account? Click here to register

[ultimatemember form_id="29399"]

If have account, Click here to login